3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one

C31H29F6N3O2 — CID 163707409

IUPAC3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one
SMILESCC(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)C(c1ccccc1)N1CCC(n2c(=O)[nH]c3ccccc32)C1
InChIInChI=1S/C31H29F6N3O2/c1-19(11-12-20-15-22(30(32,33)34)17-23(16-20)31(35,36)37)28(41)27(21-7-3-2-4-8-21)39-14-13-24(18-39)40-26-10-6-5-9-25(26)38-29(40)42/h2-10,15-17,19,24,27H,11-14,18H2,1H3,(H,38,42)
InChIKeyKGGLRWVPCCRUMV-UHFFFAOYSA-N
MW589.58 g/mol
LogP7.19
Rot. Bonds8

About 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one

3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one (PubChem CID 163707409) has the molecular formula C31H29F6N3O2 and a molecular weight of 589.58 g/mol. Its IUPAC name is 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one.

Molecular Properties

Compound Name3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one
PubChem CID163707409
Molecular FormulaC31H29F6N3O2
Molecular Weight589.58 g/mol
Exact Mass589.22
IUPAC Name3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one
SMILESCC(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)C(c1ccccc1)N1CCC(n2c(=O)[nH]c3ccccc32)C1
InChIInChI=1S/C31H29F6N3O2/c1-19(11-12-20-15-22(30(32,33)34)17-23(16-20)31(35,36)37)28(41)27(21-7-3-2-4-8-21)39-14-13-24(18-39)40-26-10-6-5-9-25(26)38-29(40)42/h2-10,15-17,19,24,27H,11-14,18H2,1H3,(H,38,42)
InChIKeyKGGLRWVPCCRUMV-UHFFFAOYSA-N
XLogP7.19
TPSA58.10 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds8
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500589.58
LogP ≤ 57.19
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one?
The IUPAC name of 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one (CID 163707409) is 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one.
What is the SMILES notation for 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one?
The canonical SMILES for 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one is CC(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)C(c1ccccc1)N1CCC(n2c(=O)[nH]c3ccccc32)C1.
What is the InChIKey of 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one?
The InChIKey is KGGLRWVPCCRUMV-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H29F6N3O2/c1-19(11-12-20-15-22(30(32,33)34)17-23(16-20)31(35,36)37)28(41)27(21-7-3-2-4-8-21)39-14-13-24(18-39)40-26-10-6-5-9-25(26)38-29(40)42/h2-10,15-17,19,24,27H,11-14,18H2,1H3,(H,38,42).
What are the key properties of 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one?
3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one has a molecular weight of 589.58 g/mol, XLogP of 7.19, 8 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-3-methyl-2-oxo-1-phenylpentyl]pyrrolidin-3-yl]-1H-benzimidazol-2-one is sourced from PubChem (CID 163707409), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).